Get the Stockscreener App
22.82
4.18%
-0.9957
Precipio Inc stock is traded at $22.82, with a volume of 5,316.
It is down -4.18% in the last 24 hours and down -4.98% over the past month.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
See More
Previous Close:
$23.82
Open:
$23.77
24h Volume:
5,316
Relative Volume:
0.44
Market Cap:
$41.59M
Revenue:
$21.24M
Net Income/Loss:
$-1.80M
P/E Ratio:
-18.87
EPS:
-1.2094
Net Cash Flow:
$565.00K
1W Performance:
-2.50%
1M Performance:
-4.98%
6M Performance:
+89.41%
1Y Performance:
+286.85%
1-Day Range:
$23.50
$24.00
1-Week Range:
$22.50
$24.92
52-Week Range:
$3.90
$28.50
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
12325 EMMET ST, OMAHA, CT
Compare PRPO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
23.74 | 41.59M | 21.24M | -1.80M | 565.00K | -1.2094 |
|
TMO
Thermo Fisher Scientific Inc
|
622.58 | 229.63B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
237.35 | 166.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
691.95 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.66 | 40.52B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
238.72 | 39.95B | 15.90B | 1.28B | 2.21B | 7.2842 |
Precipio Inc Stock (PRPO) Latest News
(PRPO) Volatility Zones as Tactical Triggers - Stock Traders Daily
The Truth About Precipio Inc (PRPO): Tiny Stock, Huge Hype – Or Total Trap? - AD HOC NEWS
Precipio, Inc. Achieves 351.85% Return, Leading Pharmaceutical Sector Performance - Markets Mojo
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio - sharewise.com
Understanding the Setup: (PRPO) and Scalable Risk - Stock Traders Daily
Contrasting Health Catalyst (NASDAQ:HCAT) & Precipio (NASDAQ:PRPO) - Defense World
Is Precipio Inc. stock trading at a premium valuationMarket Performance Report & Safe Capital Growth Trade Ideas - Улправда
Operating cash flow per share of Precipio, Inc. – MUN:TGK - TradingView — Track All Markets
How Precipio Inc. stock reacts to Fed rate cuts2025 Geopolitical Influence & Weekly High Return Stock Opportunities - Улправда
Gainers Report: Can Precipio Inc. stock maintain growth trajectoryMarket Risk Summary & Community Verified Watchlist Alerts - Улправда
Is Precipio Inc. stock cheap at current valuationWeekly Investment Recap & Safe Swing Trade Setup Alerts - Bölüm Sonu Canavarı
Investment Recap: How Precipio Inc. stock reacts to Fed rate cuts2025 Momentum Check & Weekly High Return Opportunities - ulpravda.ru
Why Precipio Inc. stock remains on watchlistsJuly 2025 Institutional & Entry Point Confirmation Signals - Улправда
Precipio Earnings Notes - Trefis
How (PRPO) Movements Inform Risk Allocation Models - Stock Traders Daily
Privia Health Group (NASDAQ:PRVA) vs. Precipio (NASDAQ:PRPO) Critical Contrast - Defense World
Precipio, Inc. to Showcase Its BCR: - marketscreener.com
Precipio, Inc. to Present Findings on BCR::ABL1 Assay at ASH Meeting Demonstrating Enhanced Performance and Patient Care Impact - Quiver Quantitative
Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting - GlobeNewswire
Precipio identifies unauthorized access to isolated storage; no operational impact - marketscreener.com
Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact - marketscreener.com
Precipio (PRPO) details limited cloud data access; reports no impact to operations, patients or finances - Stock Titan
Trading Systems Reacting to (PRPO) Volatility - Stock Traders Daily
Is Precipio Inc a good long term investmentRisk-Reward Ratio Analysis & Reduce Losses With Smart Exit Strategies - earlytimes.in
How Precipio Inc. (PRPO) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Precipio announces executive option grants tied to stock performance - MSN
Precipio, Inc. Hits New 52-Week High of $27.29, Up 356.52% - Markets Mojo
Precipio, Inc. Hits New 52-Week High of $28.50, Up 345.57% - Markets Mojo
Precipio COO Sabet buys $505 worth of shares By Investing.com - Investing.com UK
Precipio COO Sabet buys $487 in company stock By Investing.com - Investing.com Australia
Precipio COO Sabet buys $487 in company stock - Investing.com
[Form 4] Precipio, Inc. Insider Trading Activity - Stock Titan
Precipio COO Sabet buys $505 worth of shares - Investing.com India
Can Precipio Inc. stock deliver sustainable ROE2025 Market Sentiment & Reliable Intraday Trade Alerts - newser.com
Precipio (NASDAQ:PRPO) & Alternate Health (OTCMKTS:AHGIF) Critical Contrast - Defense World
Can Precipio Inc. stock continue upward trendWeekly Profit Report & Consistent Return Strategy Ideas - newser.com
Why Precipio Inc. stock is favored by pension funds2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
Is this a good reentry point in Precipio Inc.Quarterly Profit Report & AI Enhanced Market Trend Forecasts - newser.com
Precipio Stock Up Following Solid Q3 Earnings and Improved Cash Flow - Nasdaq
What earnings revisions data tells us about Precipio Inc.July 2025 Action & Community Consensus Picks - newser.com
Historical volatility pattern of Precipio Inc. visualizedWeekly Profit Report & Proven Capital Preservation Methods - newser.com
Precipio, Inc. (NASDAQ:PRPO) Stock Rockets 28% But Many Are Still Ignoring The Company - simplywall.st
Earnings call transcript: Precipio Q3 2025 sees strong growth and positive EBITDA - Investing.com Nigeria
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Precipio Inc Stock (PRPO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sabet Ahmed Zaki | Chief Operating Officer |
Jul 08 '25 |
Buy |
16.30 |
31 |
505 |
690 |
| LAPORTE KATHLEEN | Director |
Sep 08 '25 |
Sale |
20.06 |
6,152 |
123,409 |
6,151 |
1.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):